{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-065140","form_type":"8-K","ticker":"INBX","cik":"0002007919","company_name":"Inhibrx Biosciences, Inc.","filed_at":"2024-05-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.401353+00:00","generated_at":"2026-06-01T08:55:04.079801+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Inhibrx Biosciences spin-off registration effective; distribution May 29, merger with Sanofi May 30","bullets":["Registration statement on Form 10 declared effective by SEC on May 24, 2024.","Distribution of 92% of Inhibrx Biosciences shares to RemainCo holders at 1:4 ratio; effective May 29.","RemainCo merger with Sanofi expected to close May 30, subject to conditions.","When-issued trading under INXBV from May 28; regular-way under INXB from May 30; then INBX from May 31."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-065140","json":"https://secwatch.observer/filing/0001104659-24-065140.json","markdown":"https://secwatch.observer/filing/0001104659-24-065140.md","text":"https://secwatch.observer/filing/0001104659-24-065140.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2007919/000110465924065140/0001104659-24-065140-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2007919/000110465924065140/tm243190d17_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T08:55:04.079801+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}